| Literature DB >> 20226889 |
Kulkanya Chokephaibulkit1, Nottasorn Plipat, Sutee Yoksan, Wanatpreeya Phongsamart, Keswadee Lappra, Pimpanada Chearskul, Sanay Chearskul, Orasri Wittawatmongkol, Nirun Vanprapar.
Abstract
We report a prospective study of mouse brain derived inactivated Japanese encephalitis (JE) vaccine, given in 3-dose EPI program to human immune deficiency virus (HIV)-exposed Thai infants. 18 HIV-infected receiving antiretroviral therapy with median baseline CD4 of 33.1%, and 92 HIV-uninfected children were studied. All but one HIV-infected child seroconverted after the second dose. The geometric mean titers (GMTs) 3 months after the second and third doses in HIV-infected vs HIV-uninfected children were 247 vs 938 (p=0.022), and 2273 vs 24069 (p=0.009), respectively. Urticaria or angioedema found in 4% and 6% in HIV-infected and -uninfected children, respectively (p=1.0). The vaccine was safe and immunogenic but antibody response in HIV-infected children was not as high as in uninfected children. (c) 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20226889 DOI: 10.1016/j.vaccine.2010.02.108
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641